B Cell Response Induced by SARS-CoV-2 Infection Is Boosted by the BNT162b2 Vaccine in Primary Antibody Deficiencies

Background: Patients with primary antibody deficiencies are at risk in the current COVID-19 pandemic due to their impaired response to infection and vaccination. Specifically, patients with common variable immunodeficiency (CVID) generated poor spike-specific antibody and T cell responses after immu...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Federica Pulvirenti, Ane Fernandez Salinas, Cinzia Milito, Sara Terreri, Eva Piano Mortari, Concetta Quintarelli, Stefano Di Cecca, Gianluca Lagnese, Alessandra Punziano, Marika Guercio, Livia Bonanni, Stefania Auria, Francesca Villani, Christian Albano, Franco Locatelli, Giuseppe Spadaro, Rita Carsetti, Isabella Quinti
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	MDPI AG 2021-10-01
Saila:	Cells
Gaiak:	common variable immunodeficiencies SARS-CoV-2 COVID-1 BNT162b2 vaccine third dose
Sarrera elektronikoa:	https://www.mdpi.com/2073-4409/10/11/2915
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!